JLABS @ SSF
329 Oyster Point Boulevard, Floor 3
South San Francisco, CA
Wilson Sonsini Presentation: Mastering IP Diligence for VC Investments and BioPharma Partnering
To make informed investment decisions and assess the risks and opportunities effectively, life science venture capitalists and biopharma must conduct thorough IP diligence when evaluating potential opportunities in this space. We’ll cover IP due diligence, patents, freedom-to-operate, IP licensing and IP litigation so a company can confidently present its IP assets to VCs and biopharma.
To read the full event description, and agenda visit the event website to register and learn more.
Katie Stonum
kstonum@wsgr.comDr. Laurie McNamara is a partner in the San Diego and San Francisco offices of Wilson Sonsini Goodrich & Rosati, where she focuses her practice on matters related to intellectual property and patent prosecution strategy for early-stage through clinical stage therapeutics companies. She counsels clients on matters related to global patent portfolio development and strategy, non-infringement, patentability, and freedom-to-operate studies. She advises company clients in connection with major financial transactions such as collaboration agreements, venture financings, merger & acquisitions, and public offerings. In addition to company-side representation, Laurie works with top venture capital firms related to IP diligence of target companies for financings. Laurie has represented venBio, OrbiMed, Logos Capital, Venrock, Foresight Capital, Novo Holdings, Vida Ventures, Avalon BioVentures, Two Bear Capital, and Samsara BioCapital, in connection with financings of target companies developing biologics therapeutic programs.